Arch Therapeutics, Inc.
Arch Therapeutics, Inc.
Your view on ARTH
Overview
What the company does, where it operates, and who runs it.
About Arch Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Terrence W. Norchi
- Headquarters
- 235 Walnut Street, Framingham, MA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Terrence W. Norchi
- Headquarters
- 235 Walnut Street, Framingham, MA, US
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.